Open AccessPatients with refractory catastrophic antiphospholipid syndrome respond inconsistently to eculizumab
Author(s) -
Cécile Yelnik,
S. Miranda,
A. Mékinian,
Estibaliz Lazaro,
Thomas Quéméneur,
François Provôt,
Marie Frimat,
S. MorellDubois,
Véronique Le Guern,
É. Hachulla,
N. CostedoatChalumeau,
M. Lambert
Publication year - 2020
Publication title -
blood
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.515
H-Index - 465
eISSN - 1528-0020
pISSN - 0006-4971
DOI - 10.1182/blood.2020007499
Subject(s) - eculizumab , catastrophic antiphospholipid syndrome , antiphospholipid syndrome , refractory (planetary science) , medicine , immunology , thrombosis , complement system , antibody , biology , astrobiology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom